Search Results 571-580 of 5681 for albumin

  1. A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma - Mayo Clinic

    ... albumin ≤ 3.0 g/dL at Screening. Subject has any abnormalities in serum sodium, potassium, chloride, calcium and magnesium levels ≥ Grade 2 at screening ...

  2. Rehabilitation program elements - Mayo Clinic

    Home-based pulmonary rehabilitation program elements. Based on Respiratory Care 2018.

  3. Cytogenetics Laboratory - Laboratory Medicine and Pathology - Mayo Clinic

    The Cytogenetics Lab provides comprehensive testing services including chromosome analysis, probes, FISH and microarray congenital disorder assays.

  4. Popliteal artery aneurysm - Doctors and departments - Mayo Clinic

    Learn more about this lower extremity aneurysm that occurs in the wall of an artery located behind the knee.

  5. Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    dipstick, significant proteinuria [>300 mcg albumin/mg creatinine]), other significant renal disease, renal cancer, transplanted kidney, single kidney ...

  6. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Stage 3 Liver Fibrosis - Mayo Clinic

    Serum albumin < 3.5 g/ dL;; Platelet count < 100 × 103/μL;; International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting ...

  7. Tests and treatments - Mayo Clinic

    At Mayo Clinic, you have access to the latest advances and proven innovations for diagnosing and treating cancer. Not all services are provided at all ...

  8. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Documented serum albumin <3 g/dL at Screening, and within 72 hours prior to first dose if first dose occurs more than 72 hours post screening (both labs at ...

  9. First-in-Human Study of KO-947 in Non-Hematological Malignancies - Mayo Clinic

    Serum albumin ≥ 2.8 g/dL. Acceptable liver function: Bilirubin ≤ 1.5 times upper limit of normal (x ULN); if liver metastases are present, then ≤ 2 x ULN ...

  10. Division of Clinical Microbiology - Laboratory Medicine and Pathology

    Mayo enterprise laboratories have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods to ...